- Home
- WFC vs AZN Comparison
WFC vs AZN Comparison
Compare WFC & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFC
- AZN
- Stock Information
- Founded
- WFC 1852
- AZN 1992
- Country
- WFC United States
- AZN United Kingdom
- Employees
- WFC N/A
- AZN N/A
- Industry
- WFC Major Banks
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- WFC Finance
- AZN Health Care
- Exchange
- WFC Nasdaq
- AZN Nasdaq
- Market Cap
- WFC 249.8B
- AZN 212.2B
- IPO Year
- WFC N/A
- AZN 1993
- Fundamental
- Price
- WFC $77.09
- AZN $66.60
- Analyst Decision
- WFC Buy
- AZN Buy
- Analyst Count
- WFC 21
- AZN 9
- Target Price
- WFC $72.52
- AZN $88.80
- AVG Volume (30 Days)
- WFC 16.0M
- AZN 5.0M
- Earning Date
- WFC 01-15-2025
- AZN 02-06-2025
- Dividend Yield
- WFC 2.08%
- AZN 2.23%
- EPS Growth
- WFC 11.18
- AZN 9.79
- EPS
- WFC 5.37
- AZN 4.15
- Revenue
- WFC $77,962,000,000.00
- AZN $51,206,000,000.00
- Revenue This Year
- WFC N/A
- AZN $18.56
- Revenue Next Year
- WFC $4.49
- AZN $7.44
- P/E Ratio
- WFC $14.35
- AZN $31.70
- Revenue Growth
- WFC 0.99
- AZN 13.81
- 52 Week Low
- WFC $46.38
- AZN $60.47
- 52 Week High
- WFC $78.13
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- WFC 69.70
- AZN 50.73
- Support Level
- WFC $69.34
- AZN $64.22
- Resistance Level
- WFC $76.82
- AZN $67.57
- Average True Range (ATR)
- WFC 1.50
- AZN 0.85
- MACD
- WFC 0.66
- AZN 0.12
- Stochastic Oscillator
- WFC 97.98
- AZN 67.04
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.